Aniracetam: A Comprehensive Overview of its Nootropic Properties
Aniracetam, also known as 1-p-anisoyl-2-pyrrolidinone, is a nootropic drug that is used to improve cognitive function. It is a member of the racetam family of drugs, which are known for their ability to enhance memory, focus, and concentration. Aniracetam is believed to work by increasing the levels of the neurotransmitter acetylcholine in the brain, which is involved in learning and memory. It is also thought to have an effect on the glutamate and GABA neurotransmitters, which are involved in mood and anxiety.
Aniracetam has been studied for its potential to improve cognitive function in people with Alzheimer's disease, dementia, and other age-related cognitive decline. It has also been studied for its potential to improve mood and reduce anxiety. In addition, it has been studied for its potential to improve focus and concentration.
Positive Effects of Aniracetam
- Improves cognitive function
- Enhances memory and learning
- Improves focus and concentration
- Reduces anxiety and improves mood
- May help with age-related cognitive decline
Possible Negative Effects of Aniracetam
The recommended dosage of Aniracetam is 750-1500 mg per day, taken in two or three divided doses. It is important to start with a lower dose and gradually increase it to avoid side effects. It is also important to take Aniracetam with a meal that contains fat, as this helps to increase its absorption.
History of Aniracetam
Aniracetam was first developed in the 1970s by the pharmaceutical company Hoffman-La Roche. It was initially developed as a treatment for Alzheimer's disease, but it was found to have nootropic properties as well. Since then, it has been studied for its potential to improve cognitive function and reduce anxiety. It is currently available as a dietary supplement in many countries, but it is not approved by the FDA for medical use in the United States.